GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » COGS-to-Revenue

Curocell (XKRX:372320) COGS-to-Revenue : 0.00 (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell COGS-to-Revenue?

Curocell's Cost of Goods Sold for the six months ended in Jun. 2023 was ₩0.00 Mil. Its Revenue for the six months ended in Jun. 2023 was ₩0.00 Mil.

Curocell's COGS to Revenue for the six months ended in Jun. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Curocell's Gross Margin % for the six months ended in Jun. 2023 was N/A%.

Curocell COGS-to-Revenue Historical Data

The historical data trend for Curocell's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell COGS-to-Revenue Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
- 0.40 - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue - - - -

Curocell COGS-to-Revenue Calculation

Curocell's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Curocell's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curocell  (XKRX:372320) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Curocell's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Curocell COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Curocell's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » COGS-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines